Eterna Therapeutics Inc (ERNA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.30
• Market Cap: $7.94M
• P/E Ratio: 0.01
• EPS: $56.32
• 52-Week High: $4.50
• 52-Week Low: $0.27

Market Sentiment

Eterna Therapeutics Inc currently has a Bullish sentiment score of 0.32.

About Eterna Therapeutics Inc

Eterna Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in Brooklyn, New York, dedicated to advancing innovative immunotherapy solutions to address critical unmet needs in cancer treatment. By harnessing cutting-edge technology platforms, Eterna aims to redefine the therapeutic landscape and improve patient outcomes in oncology. With a robust commitment to research and strategic collaborations, Eterna is positioned to deliver significant advancements and value wit...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Eterna Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ERNA pay dividends?

Eterna Therapeutics Inc (ERNA) does not currently pay a regular dividend.

What is ERNA's P/E ratio?

Eterna Therapeutics Inc has a price-to-earnings (P/E) ratio of 0.01.

What is ERNA's market cap?

Eterna Therapeutics Inc (ERNA) has a market capitalization of $7.94M with a current stock price of $0.30.